Compare AES Corp (AES) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AES Corp vs Mesoblast Limited — how do they compare? AES Corp trades at $14.7 (market cap $10.49B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: AES Corp is far larger — about 4.7× Mesoblast Limited's market cap, and AES Corp pays a 4.79% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| AES | MESO | |
|---|---|---|
Market Cap | $10.49B | $2.21B |
Sector | Utilities | Technology |
52-Week High | $17.28 | $20.96 |
52-Week Low | $12.51 | $12.88 |
Enterprise Value | $40.75B | $2.21B |
Dividend Yield | 4.79% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AES Corp
AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
